Cancer Genetics Network approved By NCI Advisors, To Start With 8 Centers
In Brief: FDA commissioner Kessler To Resign, Says His Goals Were Accomplished
NCI Initiative: Start With Mechanism, Then answer The Many Questions, Klauser Says to Advisors
Patient Advocacy: Prostate Cancer Agenda Didn’t Include NCI Plans, Lausner Says
National Policy: IOM Seeks Nominations for Cancer Policy Board
Grants Funding: R01 Payline To tighten To 22nd Percentile This Year, NCI Says.
Trending Stories
- Preparing to take care of each other in ways we never imagined
- 20 years of EGFR research: Ramalingam, Carbone, Politi, Jänne, Govindan reflect
- From the chairs of ECOG-ACRIN: A perspective on indirect costs
- On a new podcast, VCU’s Winn and City of Hope’s Carpten discuss the mission—and the future—of cancer centers
The Cancer Letter’s new podcast offers insight into cancer policy in a landscape of uncertainty - FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns”